Learn More
Invitrogen™ CRG-L2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA14325
Description
PA1-4325 detects CRG-L2 in human samples. PA1-4325 has been successfully used in Western blotting procedures. The predicted molecular weight is 48 kDa. By Western blot, this antibody detects a protein often above ~50 kDa representing CRG-L2. This protein can form dimers. PA1-4325 immunizing peptide corresponds to amino acid residues 160-176 of human CRG-L2.
CRG-L2 is a protein that contains olfactomedin-like and collagen-like domains. The encoded protein, which exists in both transmembrane and secreted forms, promotes formation of the nodes of Ranvier in the peripheral nervous system. Mutations in this gene cause a form of lethal congenital contracture syndrome in human patients. Autoantibodies to the encoded protein have been identified in sera form patients with multifocal motor neuropathy.
Specifications
CRG-L2 | |
Polyclonal | |
Unconjugated | |
Gldn | |
cancer related gene - liver 2; cancer-related gene liver 2 protein; Clom; collomin; COLM; colmedin; Crgl2; CRG-L2; Crlg2; FLJ23917; Gldn; Gliomedin; Gliomedin shedded ectodomain; olfactomedin-related protein; UNC-112; UNQ9339/PRO34011 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
342035 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
Q6ZMI3 | |
Gldn | |
Synthetic peptide: L(160) V G K A D E K A S E H H S P Q A(176). | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.